Evaluation of the Safety of Varivax® in Pediatric Renal Transplant Recipients
Public ClinicalTrials.gov record NCT00005009. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of the Safety and Immunogenicity of Varivax® (Live-Attenuated Varicella-Zoster Virus Vaccine) in Pediatric Renal Transplant Recipients
Study identification
- NCT ID
- NCT00005009
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Enrollment
- 7 participants
Conditions and interventions
Conditions
Interventions
- Varivax® Biological
Biological
Eligibility (public fields only)
- Age range
- 2 Years to 21 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 1998
- Primary completion
- Jun 15, 2001
- Completion
- Jun 15, 2001
- Last update posted
- Feb 15, 2017
1998 – 2001
United States locations
- U.S. sites
- 4
- U.S. states
- 4
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham - Vaccine and Treatment Evaluation Unit (VTEU) | Birmingham | Alabama | 35401 | — |
| Boston Children's Hospital - Vaccine and Treatment Evaluation Unit (VTEU) | Boston | Massachusetts | 02115 | — |
| University of Michigan - Vaccine and Treatment Evaluation Unit (VTEU) | Ann Arbor | Michigan | 48103 | — |
| University of Texas Health Science Center at San Antonio - Vaccine and Treatment Evaluation Unit (VTEU) | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00005009, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 15, 2017 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00005009 live on ClinicalTrials.gov.